This paper investigates the variation in the effects of various determinants on the per capita health-care expenditure. A total of 28 Organisation for Economic Co-operation and Development countries are studied over the period 1990-2012, employing an instrumental variable quantile regression method for a dynamic panel model with fixed effects. The results show that the determinants of per capita health-care expenditure growth, involving the growth of lagged health spending, of per capita gross domestic product (GDP), of physician density, of elderly population, of life expectancy, of urbanization, and of female labor force participation, do vary with the conditional distribution of the health-care expenditure growth, while the changing patterns are dissimilar. Moreover, we show that Baumol's model of "unbalanced growth" has a significantly positive effect on per capita health spending growth, and its effect is quite stable over the entire distribution. However, the correlation between the components (wage growth and labor productivity growth) of the "Baumol variable" and health expenditure growth is more varied. As a comparison, only the growth of lagged health spending, per capita GDP, and the Baumol variable (or its components) are found related to health spending growth in conditional mean regressions.
studies have found that the level and growth of HCE across OECD countries eventually converge; those that had a low (or high) initial level of HCE tend to grow faster (or slower; convergence theory) (see, e.g., Okunade, Karakus, & Okeke, 2004; Kerem, Püss, Viies, & Maldre, 2008; Payne, Anderson, Lee, & Cho, 2015) , which implies that the effects of determinants should not be linear, and these may vary with the health-care spending (or growth). Most studies in the literature have ignored this when estimating parameters in a standard linear regression and have focused on average effects. In this article, we adopt a quantile regression method that also gives more flexibility with no distributional assumptions on the innovations in order to investigate whether the effects of determinants change with the increase in conditional health spending growth, as such heterogeneity could have important policy implications. Meanwhile, we construct predictive density functions for these two kinds of methods, in which some important distinctions between them are illustrated.
This paper builds on the existing literature in two ways. First, as was stated above, we focus on analyzing the changes in the effects of the determinants on the conditional distribution of per capita HCE growth. The empirical literature on health expenditure growth in OECD countries has rarely considered this. To meet our aims, we use a balanced panel of data from 28 OECD countries over the period of 1990-2012 and apply a quantile regression method for panel data with fixed effects. Moreover, recent studies have found that HCE in a given year is conditioned on the previous year, indicating the existence of an "anchorage effect" ("expenditure inertia"; see, e.g., Okunade & Suraratdecha, 2000; Lago-Peñas, Cantarero-Prieto, & Blázquez-Fernández, 2013; Blazquez-Fernandez, Cantarero, & Perez, 2014; Castro, 2016) . We capture this kind of effect by including the lagged dependent variable in our models. Because a standard quantile regression to the dynamic panel data models with fixed effects is typically biased (Galvao, 2011) , this study attempts to overcome this problem by using the quantile regression dynamic panel instrumental variable (QRPIV) model (Galvao, 2011) . In addition, we construct one-step-ahead predictive density functions for each OECD country, which is useful for applications.
Second, with respect to the determinants of per capita HCE, explanatory variables other than the lagged dependent variable include not only the per capita gross domestic product (GDP), the share of the population that is old, number of physicians per 1,000 persons, and the remaining life expectancy at age 65 years, which have all been used by the relevant literature (see, e.g., Gerdtham & Jönsson, 2000; Di Matteo, 2005; Blazquez-Fernandez et al., 2014) , but also the "Baumol variable" (Baumol, 1967 , model of "unbalanced growth," defined as real wage growth minus productivity growth), which has been suggested as a theory-based determinant of HCE growth in the recent literature (see, e.g., Hartwig, 2008; Bates & Santerre, 2013; Hartwig & Sturm, 2014) . The core concepts under Baumol's model of unbalanced growth are not complicated. First, Baumol divided the economy into two parts, a "progressive" sector and a "nonprogressive" sector. Health care is included in the nonprogressive sector. And then, he assumed the growth in labor productivity can occur only in the progressive sector, while the wage rates in two sectors are equal and rise in conjunction with productivity improvements in the progressive sector. When prices rise in proportion to costs, and the price elasticity is very low (such as health care), an increased shift of expenditure into the nonprogressive sector will be revealed. Hartwig (2008) pointed out that Baumol's theory can be tested if wage increases in excess of labor productivity growth (namely, the Baumol variable) drive the rise in health expenditure in a directly proportional way. We include the Baumol variable as one of the determinants of health expenditure in this paper, in order to provide some new results from quantile analysis. Moreover, we consider some additional variables, such as sugar and natural sweeteners food supply in kilocalories per person per day (Castro, 2016) , the share of the population that is young, government expenditure on health care, percent of urban population, and female labor force participation rate (Hosoya, 2014; Castro, 2016) , which are not generally considered in the literature.
To sum up, this paper differs from the existing studies of HCE in two respects. First, we focus on the heterogeneity of the effects of determinants on the conditional distribution of per capita HCE growth and employ QRPIV method to examine health expenditure inertia. Besides, we construct one-step-ahead predictions for each OECD country. To the best of our knowledge, no existing study has explored HCE from this point of view. Second, we pay more attention on the effects of the Baumol variable on health spending, as the results from previous studies have provided us with nothing about the changing pattern of its effect. We find that the effects of some determinants do vary over the conditional distribution of health expenditure, and some interesting results (changing patterns in the effects of the determinants) are revealed.
The remainder of the paper is structured as follows. In Section 2, a review of the relevant literature is provided. Section 3 describes the dataset and the proposed empirical quantile regression model for the panel dataset. Section 4 states and then discusses the main results and some discussion on the effect of determinants on the conditional distribution of health expenditure growth. For comparison, one-step-ahead predictions are also constructed. Section 5 provides concluding remarks.
LITERATURE REVIEW
Previous researchers have usually grouped the literature on health expenditure into three different lines of inquiry (Narayan, 2006; Payne et al., 2015) . On the basis of recent developments in HCE research, we categorize the relevant literature into four main types. The first type focuses on the determinants of health expenditure, with the aim of discovering the main explanatory variables and their influences (see, e.g., Newhouse, 1977; Gerdtham, Søgaard, Andersen, & Jöns-son, 1992; Gerdtham, 1992; Hitiris & Posnett, 1992; Okunade & Suraratdecha, 2000; Sen, 2005; Baltagi & Moscone, 2010; Hosoya, 2014) . These studies find that not only does income (or per capita GDP) have a strong influence on health-care spending, but also so do some nonincome variables, though the effects of such variables appear to be small. The most frequently identified nonincome factors are the demographic dependency ratio (or the percentages of old people), the number of physicians, and the life expectancy. Some factors are also identified on occasion, such as the share of the population that is young, government HCE, percent of urban population, and female labor force participation rate. Recently, a few studies have used the Baumol variable as another explanatory variable in the regression and have found it to have a significant effect on health spending. And a fresh look at health spending has found that an increase in sugar availability can lead to a significant rise in the growth rate of the HCE per capita (Castro, 2016) . However, the most noteworthy finding in the existing literature on health expenditure is that, except for the income variable and Baumol variable, none of the factors that have been found to influence the HCE have conclusive influences; see the results in Table 1 .
The second type of research examines whether or not HCEs are stationary in the time series dimension and explores structural breaks in health spending series and the convergence of HCEs across countries (see, e.g., Barros, 1998; Hitiris & Nixon, 2001; Okunade et al., 2004; Narayan, 2006 Narayan, , 2007 Kerem et al., 2008; Payne et al., 2015) . Most of the recent studies of this type have confirmed the convergence in per capita HCEs across developed countries, once we allow for breaks in health expenditures.
The third type of study has focused on the long-run (cointegration) relationship between HCE and its determinants, as well as on differences between the short-and long-run income elasticity (IE) of HCE (see, e.g., Blomqvist & Carter, 1997; McCoskey & Selden, 1998; Okunade & Karakus, 2001; Chou, 2007; Baltagi & Moscone, 2010; Blazquez-Fernandez et al., 2014) . A number of studies have found that the presence or absence of stable relationships among variables in the regression models varies according to the sample countries and sample period. Consequently, testing for stationarity of the variables is often required prior to estimation.
The fourth type of research, which is recognized as having important policy implications across countries, focuses on the heterogeneous effects of HCE determinants. Existing studies have used two main methods to explore this heterogeneity. One involves grouping sample countries according to either their level of economic development or the sample period and then employing an empirical analysis for each group (see, e.g., Okunade & Suraratdecha, 2000; Di Matteo, 2005; Chakroun, 2010; Farag et al., 2012; Blazquez-Fernandez et al., 2014) . The other involves using nonparametric, semiparametric, or quantile regression methods to detect the varying effects of factors (see, e.g., Di Matteo, 2003; Chen, Lin, & Chang, 2009; Liu, Li, & Wang, 2011; Yu, Wang, & Chang, 2011; Chen, Vargas-Bustamante, Mortensen, & Thomas, 2014) . Heterogeneity is confirmed without exception.
To some extent, our focus in this paper is related to the fourth type. However, our study differs from the studies cited in several important aspects with respect to the heterogeneous effect of HCE. First, we examine a more recent time period and a larger range of OECD countries. Second, even though some previous research has used a quantile regression method to examine the heterogeneity in health-care spending, to the best of our knowledge, none of them have noted the importance of expenditure inertia at the same time, and hence, none of them have considered the influence of the lagged dependent variable. However, health expenditure inertia is pervasive and strong (Okunade & Suraratdecha, 2000; Blazquez-Fernandez et al., 2014; Castro, 2016) , and the results produced if ignoring this effect will be less realistic. Therefore, we include a one-period-lagged dependent variable in the regression model, and as a consequence, this paper employs a quantile regression method for dynamic panel data with fixed effects. What is more, one-step-ahead predictive density functions for each OECD country are constructed. Third, as recent studies have discerned that the Baumol variable is another key determinant of health spending, this paper uses the Baumol variable as one of the explanatory variables. Some studies on health spending have corroborated the significant influence of the Baumol variable, whereas no study has examined the heterogeneous effect of it on health spending (growth).
To a certain extent, this study is original in employing the QRPIV method to examine the heterogeneous effects of the determinants of HCE (growth), taking into account health expenditure inertia and the influence of the Baumol variable. And moreover, we construct one-step-ahead predictive density functions for each OECD country. Sen ( (1) The definitions of "IE," "Phy," "LE65," "Bau," "Sugar," "GHE," "Urban," and "Femalelfp" are provided in Section 3. "No" and "Yes" respectively indicate that the corresponding studies do not and do consider the specific variable. "+," "−," and "None" indicate that the estimated coefficient is statistically significantly positive, statistically significantly negative, and nonsignificant, respectively."/" in a result indicates that the corresponding findings vary with the regression model and the estimated technology, or at different quantiles. (2) As some of the studies used different definitions for the demographic structure, we use "old" in Table 1 to refer to the variables related to the percentages of the old populations in the relevant studies. Specifically, Gerdtham et al. (1992) , Gerdtham (1992) , and Baltagi and Moscone (2010) defined "old" as the population aged 65 years and over divided by the population aged 15-64; Breyer, Lorenz, & Niebel (2015) captured the effect of age using a set of dummy variables for each age. All of the other studies listed in Table 1 use the same definitions for "old" as we use for "POP65" in this article. (3) Gerdtham et al. (1992) also considered some dummy variables. Gerdtham (1992) also considered inflation in his model. Sen (2005) also considered infant mortality rates per 100,000 population and the average length of patient stays in hospitals. Sen (2005) and Blazquez-Fernandez et al. (2014) 
THE DATA AND MODEL
Our analysis uses an annual dataset for 28 OECD countries from 1990 to 2012, extracted from the OECD statistics, WDI database, and FAOSTAT. 1 On the basis of the availability of the annual data for every year, we exclude Chile, Iceland, Israel, New Zealand, the Slovak Republic, and Turkey. We collect the necessary information on per capita HCE (PHE) and per capita GDP (PGDP), estimated using the constant purchasing power parity rate (constant 2010 PPP) and constant prices (constant at 2010), with all amounts expressed in U.S. dollars. The other variables that we consider include the number of physicians per 1,000 persons (Phy), to represent health-care resources; the proportion of the population aged 65 years and older (POP65); the remaining life expectancy at age 65 years (averaged over both sexes; LE65) in each country; and the Baumol variable (Bau), which is defined as the difference between real wage growth and productivity growth. In addition, to explore the main driver of the effect of the Baumol variable, we split it into two separate variables, namely, per capita real wage (Wage) growth and real labor productivity (Prod) growth in the overall economy, and then we estimate the influence of these two variables separately. Taking into account the possible impact of other infrequently used variables in the literature, additionally, we add some more variables to the model and reestimate it. These variables include sugar and natural sweeteners food supply in kilocalories per person per day (Sugar); the percentage of the population younger than 15 years (POP15); government expenditure on health care (GHE), which is computed as the government HCE over total health spending; the percent of urban population (Urban), to represent the effect of urbanization on health spending; and female labor force participation rate (Femalelfp). Considering I(1) for PHE and other variables, as suggested by the existing literature on HCE, we estimate the growth rate of HCE instead of level. For the original values of PHE, PGDP, Phy, POP65, LE65, Sugar, POP15, GHE, Urban, and Femalelfp, we calculate log differences of these variables and express as dlPHE, 2 dlPGDP, dlPhy, dlPOP65, dlLE65, dlSugar, dlPOP15, dlGHE, dlUrban, and dlFemalelfp separately, which denote the growth rate of the original variables one by one. The Baumol variable is defined as the excess of log difference of per capita real wage (dlWage) over log difference of labor productivity (dlProd). The descriptive statistics are summarized in Table 2 .
To check for stationarity of the growth of PHE and other variables, Table 3 reports the results of panel unit root tests. The LLC test (Levin, Lin, & Chu, 2002) assumes that all panels have the same autoregressive parameter, whereas the IPS (Im, Pesaran, & Shin, 2003) test relaxes the assumption of a common autoregressive parameter and instead allows for each panel to have its own autoregressive root. However, the bias correction terms in the LLC test and the detrending bias in the IPS test result in a power loss (Breitung, 2001) . Therefore, the same type of panel unit root tests should be performed using a Fisher statistic (Choi, 2001) . Note that the null hypothesis of all tests is the presence of a unit root in a series. However, the alternatives differ. In the LLC and Breitung tests, there is an affirmative alternative of stationarity, whereas the alternative hypothesis in the IPS, Fisher-ADF, and Fisher-PP tests is that the fraction of the panels that is stationary is nonzero. As we can see from Table 3 , the five types of statistics all provide strong evidence (at the 1% significance level) in support of one log-level variable series (LE65) having unit roots. However, there is no matching result for the rest of the log-level variable series. On the other hand, all of the growth rates (log differences) of the original variables are stationary, which indicates that all of the log-level variables follow an I (1) On the basis of the literature already cited on HCE in OECD countries and the Hausman test result, this paper considers a fixed effects panel data model. In our model, these fixed effects are intended to capture some individual country's specific source of variability, which are not controlled for by other covariates in the model, such as variation in health status across countries and health systems characteristics differences (see, e.g., Okunade & Suraratdecha, 2000; Blazquez-Fernandez et al., 2014; Hauck & Zhang, 2016) . Surveys on health systems characteristics have been carried out by OECD Health Committee, and some findings have been published online. 3 It has been found that some characteristics of health systems (such as the different forms of user charges) can make people more discerning in their health-care choices and, hence, affect health expenditures (see, e.g., Smith, 2013; Hartwig & Sturm, 2014; Kiil & Houlberg, 2014) . From the first row to the last row, the names of countries are as follows: Sweden, Switzerland, United Kingdom, United States, Poland, Portugal, Slovenia, Spain, Luxembourg, Mexico, the Netherlands, Norway, Ireland, Italy, Japan, Korea, France, Germany, Greece, Hungary, Czech Republic, Denmark, Estonia, Finland, Australia, Austria, Belgium, and Canada [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 2
The log difference of per capita health expenditure. Note. Each panel represents the relation in a particular country, and the dashed line represents the line of zero. From the first row to the last row, the names of countries are as follows: Sweden, Switzerland, United Kingdom, United States, Poland, Portugal, Slovenia, Spain, Luxembourg, Mexico, the Netherlands, Norway, Ireland, Italy, Japan, Korea, France, Germany, Greece, Hungary, Czech Republic, Denmark, Estonia, Finland, Australia, Austria, Belgium, and Canada [Colour figure can be viewed at wileyonlinelibrary.com]
First of all, we investigate the effects of varying determinants on the per capita HCE growth by considering the following quantile regression model:
where (u) = u ( − I (u < 0)) denotes the piecewise linear quantile loss function, y it is the dependent variable, i denotes the individual fixed effect, and x it is a p-vector of covariates. K indicates the number of quantiles, so that K quantiles { 1 , … , k } are estimated simultaneously. The weights w k control the relative influence of the K quantiles { 1 , … , k } on the estimation of the i . The choice of the weights is analogous to the choice of discretely weighted L-statistics, and this paper adopts the Gaussian density weight function. When K = 1, the estimation of Model (1) is simply equal to that of a single quantile at one time. However, some researchers suggest that reweighting estimates at a few distinct quantiles is an important strategy for improving the efficiency of quantile regression estimates (e.g., Koenker, 2005) . To distinguish the effects of determinants between the extreme quantiles and nonextreme quantiles, we let K = 7 and set { 1 , … , k } to {0. 05, 0.10, 0.25, 0.50, 0.75, 0.90, 0 .95} in the empirical estimation. When applying quantile regression, one should keep in mind that the lag of the response variable y it − 1 is included in x it under the consideration of the anchorage effect of health spending. In this regard, let x it = ( it−1 ,x it ); then, Model (1) can be written as
When lagged dependent variables are involved in a quantile panel data model with fixed effects, some conventional quantile estimation methods suffer from bias effects like those in the OLS case when the time dimension is modest (Galvao, 2011) . We reduce the dynamic bias in the quantile regression fixed effect estimator by applying the instrumental variables (IVs) quantile regression method with lagged regressors as instruments in this case. Specifically, we use dlPHE it − 2 as the IV and Estimate Model (2) using the approach suggested by Galvao (2011) . In addition, noting that the stationarity requirement is embedded in the estimation process, this paper performs the empirical procedure in log differences (growth rate of original variables). In a sense, we actually detect the varying effects of determinants on the conditional growth of per capita health expenditure in the OECD countries. Writing in specific variables, y it = dlPHE it , y it − 1 = dlPHE it − 1 , andx it consist of dlPGDP it , dlPhy it , dlPOP65 it , dlLE65 it , Bau it , dlSugar it , dlPOP15 it , dlGHE it , dlUrban it , and dlFemalelfp it . When we examine the contributing factor for the effect of the Baumol variable, we replace Bau it with dlWage it and dlProd it . For the sake of simplicity, the following text omits the subscripts (except for the t − 1 subscript that is used to indicate the lag of the dependent variable).
This study also estimates a linear panel data model for comparing the results of using different methods. The linear panel data model is expressed as
When the dynamics of health expenditure are considered, Model (3) can be rewritten as follows:
As has been mentioned, we use an IV method to attenuate the bias caused by the simple OLS method for Model (4).
RESULTS

Main specification
First, we focus on the impact of frequently identified determinants and health expenditure inertia, that is, Table 4 presents the results of Models 2 and 4, with the corresponding graphs being given in Figure 3 . Model (2) is a quantile panel data model with fixed effects and lagged dependent variables, and the regression results indicate that, for all seven quantiles and linear model results, the lagged growth of per capita HCE (dlPHE t − 1 ) at time t − 1 (except for nonsignificant results at the 0.05 and 0.10 quantiles) and the growth of per capita GDP (dlPGDP) at time t both have significantly positive influences on the growth of per capita HCE, and this finding is in line with the results of some previous studies. For instance, Breyer et al. (2015) found that the lagged one-period HCE growth has a significantly positive effect on the current period growth for women in Germany over the period [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] . A comprehensive study by Barros (1998) on the relationship between the growth of PGDP and that of PHE found a significantly positive correlation between them, similar to what we find in this paper. This shows that, when looking at the influence of determinants on the growth (not the level) of per capita health expenditure, the positive effects of PGDP and health expenditure inertia that were confirmed in the level equations still hold. With respect to the influences of other determinants on the per capita health expenditure growth, Table 4 reveals some interesting findings. First, we find that the coefficients of dlPhy, dlPOP65, and dlLE65 change signs across quantiles, and none of them have a significant effect on the growth of PHE in the corresponding linear model. Obviously, as the linear model focuses on the average effect, an effect that changes signs over the distribution is likely to show up as an insignificant effect on average. In this case, the results from the linear model may be misleading, implying that the varying coefficient model is preferred.
Second, the coefficients of dlPhy are only significant at the 0.05, 0.10, 0.25, and 0.50 quantiles. The growth in per capita HCE negatively relates to the growth of Phy when the conditional growth of PHE is low, whereas the growth of Phy has an insignificant influence on the growth of PHE at the high end of the distribution. This suggests that the government may control the growth of PHE in some areas by adopting a policy of increasing the number of physicians. Third, the coefficients of dlPOP65 are significant and negative at the 0.05, 0.10, and 0.25 quantiles; insignificant at the 0.50 and 0.75 quantiles; and significant and positive at the 0.90 and 0.95 quantiles. Figure 3 clearly shows that there is an increasing trend of effects from the low to high ends of the distribution. Increasing the percentage of people aged 65 years and older will not always boost the per capita health spending growth but tends to cut down the per capita health spending growth at the lower quantiles, while having a positive effect on the health expenditure at the high end. This result gives us a new understanding of the influence of aging on health expenditure. Actually, Table 1 shows that existing studies found no consistent result as to the direction of the effect of an increase in the percentage of the population aged 65 years and older, possibly because almost all of the previous findings were obtained using linear models. One exception is Liu et al. (2011) , who used a semiparametric panel varying coefficient model and found that the impacts of POP65 and other nonincome variables on HCE changed at different levels of economic development. To some extent, the findings of Liu et al. (2011) support our findings.
Another interesting finding is that the coefficients of dlLE65 change from negative to positive across a range of quantiles, and there is also an increasing trend of effect as dlPOP65, with a similar changing pattern being shown in Figure 3 . That means that the absolute effect of an extension of life span is much bigger at the extreme quantiles (0.05, 0.10, 0.75, 0.90, 0.95), with an increase in the remaining life expectancy at age 65 years lessening the growth of PHE at the lower tail of the distribution, while increasing the pressure to control the health expenditure in areas with a speeding up of PHE growths.
There are two opposing ideas about the possible influence of life expectancies on health expenditure in the literature. On the one hand, some studies have found that individuals who are close to death generally receive intensive medical services (Lubitz & Prihoda, 1984; Lubitz & Riley, 1993) . Thus, the proximity to death is a good predictor of HCEs, and an increase in longevity does not matter much for the forecasting of health spending (Lubitz, Cai, Kramarow, & Lentzner, 2003; Shang & Goldman, 2008; Bjørner & Arnberg, 2012; Hyun, Kang, & Lee, 2015) . This suggests that terminal health costs are postponed with the increase in life expectancy. If two countries have similar demographic structures but different life expectancies, the one with the higher life expectancy will probably spend less on health care, because it has fewer people who are near their deaths. On the other hand, when people expect to live a longer life, they tend to spend more on health care; this is known as the "Eubie Blake effect" (Breyer et al., 2015) . These two sides of the argument suggest that the net effect of life expectancy on health expenditure will be a trade-off between these two effects. When the former dominates, there will be a negative relationship between life expectancy and health expenditure; otherwise, a positive relationship will appear. Combining those two opposing views, we think that these two kinds of effects exist simultaneously in society. When the Eubie Blake effect is bigger in absolute effect, the overall effect of life expectancy is positive; otherwise, the overall effect is negative. Considering the heterogeneity in the effect of the determinants, we find that the Eubie Blake effect is weak at the lower tail of the conditional distribution of growth of PHE, with an increase in life expectancy decreasing the growth of per capita HCE. At the higher tail of the distribution, though, this kind of effect becomes stronger and stronger, becoming the force with the largest absolute effect. To the best of our knowledge, our study is the first to obtain results that support both kinds of effects that have been found in the existing research. Further research should investigate the proportions of each kind of effect in an area. A good look at Table 4 shows that the signs of the coefficients of dlPOP65 and dlLE65 at each quantile correspond, and their changing patterns are similar, as Figure 3 shows. Obviously, this is not an accidental result, as an increase in life expectancy will increase the proportion of older people in a society, ceteris paribus. In this regard, this feature provides further support for our previous findings.
In addition, last but not least, another interesting finding is that, for all seven quantiles and linear model result, the estimated coefficients on the Baumol variable are all positive and significant, which confirmed its robustness as in the recent literature. The estimates suggest that a percentage point increase in the Baumol variable raises the growth rate of per capita HCE by about 0.434 percentage points on the average. This is lower than the coefficient values found in Hartwig (2008) , which were around 1, and in Hartwig and Sturm (2014) , which were in the range of 0.7-0.9.
To establish whether the effects of the determinants vary based on the per capita health expenditure growth conditional distribution, Table 4 presents quantile regressions for = 0.05, 0.10, 0.25, 0.50, 0.75, 0.90, 0.95. Chi-square statistics testing for the equality of the estimated coefficients at various quantiles are presented in Table 5 . For the lagged per capita health expenditure growth dlPHE t − 1 , Table 5 shows that, of the results for seven quantiles, almost all of 21 pairs of quantiles are significantly different from each other. This indicates that the growth of health spending in the current period is affected less by its previous level in countries with slow growth of per capita health expenditure growth than in those with rapid growth. Thus, there is a clear increase in health expenditure inertia over the per capita health expenditure growth distribution. In other words, it is harder to change health spending in countries with rapid growth of health expenditure growth than in those with slow growth.
For the per capita GDP growth, only seven pairs of quantiles are insignificantly different from each other. Combining these results with the analysis for dlPHE t − 1 , we find that the long-run IE varies over the distribution. It is easy to calculate and find that the long-run elasticity is smaller than unity; our results support the view that health care is a necessity. The per capita health expenditure grows in an affordable way.
When considering the growth in the number of physicians per 1,000 persons, eight out of 21 pairs of quantiles are significantly different from each other. This confirms the heterogeneity of the influence of the supply side of HCE. Countries with a slow growth in per capita health expenditure but a high level of health spending could control the growth of per capita health expenditure by adopting the policy of increasing the number of physicians.
For social aging, the influence of the growth of the percentage population aged 65 years and older (dlPOP65) on the per capita health expenditure growth differs significantly between quantiles. For a given percentage increase in the older population, the growth in per capita health expenditure is positive in countries with higher levels of conditional growth of health spending but negative in countries with lower levels. This implies that the relationship between the growth of aging population and the health expenditure is not constant and that the influences of the old populations depend on the growth stage of the per capita health expenditure in a particular area. The test results for the equality of the effect of the remaining life expectancy at various quantiles show that all of the quantile pairs are significantly different, except for the pair ( = 0.90, = 0.95). Similar to that of the influence of the percentage of the population aged 65 years and older, the changing pattern of the effect of dlLE65 has an upward trend. The same extension of the expected life span induces a decrease in health spending growth in countries with a lower level of conditional growth, while bringing an increase in health spending growth in countries with a higher level of conditional growth, if all other factors are held constant. In this regard, health expenditure control under the situation of prolonged longevity is more difficult in countries with higher levels of conditional growth of per capita health expenditure.
Another notable result shown in Table 5 is that all of the quantile pairs are insignificantly different from each other for the Baumol variable. The effects of Baumol's model of unbalanced growth on the per capita health expenditure growth are quite stable over the entire distribution. For the same expanding gap between wage growth and labor productivity growth, the positive effect of it on conditional growth of per capita health expenditure is approximately equal among OECD countries. All these countries face the same challenge in controlling the effects of Baumol's model of unbalanced growth.
To summarize, the influences of those determinants (all except the Baumol variable) on the per capita health expenditure growth in OECD countries do vary with the conditional distribution of the health spending growth. It is particularly important to distinguish these differences when considering health policy across countries. In addition, some variables (dlPhy, dlPOP65, and dlLE65) go undetected in the linear model because the influences of those variables change signs over the conditional distribution of per capita health expenditure growth; careful consideration for those variables would be needed when we care about taking steps to restrain health expenditure growth.
Some more results from variable splitting
Not like the well-established finding about the positive correlation between HCE and GDP in the literatures since 1970s, or other widely discussed variables, such as old population percentage and life expectancy, the Baumol variable has not been confirmed about its explanation for the rise in health-care spending before the study of Hartwig (2008) . In this study, Hartwig defined the Baumol variable as wage increases in excess of productivity growth, and split the Baumol variable to test whether combining them together to one variable is legitimate before his final estimation. Inspired by this and our findings about the stable effect of the Baumol variable on health expenditure growth, we split the Baumol variable into two variables, namely, per capita wage growth (dlWage it ) and labor productivity growth (dlProd it ), and then we reestimate. The results are provided in Table 6 , with the corresponding changing pattern being shown in Figure 4 . Table 7 contains the results of chi-square tests for the equality of the estimated coefficients across quantiles, as per Table 5 . Table 6 shows that, apart from two component variables of the Baumol variable, for each of the remaining determinant, the significance of the results estimated from Models 2 and 4 is similar to that in Table 4 . The changing patterns corresponding to the influence of dlPHE t − 1 , dlPhy, dlPOP65, and dlLE65, which are illustrated in Figure 4 , are also similar to those depicted in Figure 3 . For the chi-square test results, once again, the results corresponding to dlPHE t − 1 , dlPhy, dlPOP65, and dlLE65 presented in Table 7 are consistent with our earlier results. Thus, our conclusions about the varying effect of these variables stated in the previous section do not hinge on the Baumol variable splitting.
With the comparison of the results in Tables 4 and 6 , and the other corresponding results in Figures 3 and 4 and Tables 5  and 7 , some noticeable results show up. First, no statistical difference in the effect of dlGDP is found between the quantiles after we split the Baumol variable. Second, and more striking, compared with the stable effect of the Baumol variable shown in Table 4 , the correlation between the components of the Baumol variable and health expenditures growth is more varied. The coefficients of wage growth are all significant and positive. And 15 out of 21 pairs of quantiles are significantly different from each other. There is a significantly increasing trend of effect. For a given percentage increase in the wage growth, countries with high levels of conditional growth of per capita health spending suffer more strongly than do those with low levels. However, the coefficients of the other component variable, productivity growth, are only significant and These results indicate that the growth of wage drives the rise in health expenditure growth in a dramatic way, whereas the growth of labor productivity can only restrain health-care spending when the conditional growth of per capita health expenditure is below a certain level. After the conditional growth rate of HCE exceeds some certain level, Baumol's model of unbalanced growth seems not well supported by the data, because only one of the two components of the Baumol variable has a significant effect on health spending growth. Thus, the combination of these two variables is illegitimate. One potential explanation is due to the definition of the Baumol variable used in Hartwig (2008) and this study. To avoid problems surrounding productivity measurement in the health sector, we define the Baumol variable in the same way as by Hartwig (2008) , which means that we define it as wage growth in excess of productivity growth in the overall economy, not just in the health sector. It is not hard to find that this definition is not exactly consistent with the Baumol (1967) model. To find more implications for the impact of Baumol's model of unbalanced growth on health expenditure growth, an improved definition of the Baumol variable should be required in the future.
Consideration of additional variables
In this section, we consider some additional variables that do not often reveal significant effects on health spending under linear models in the literature. These additional variables include dlSugar, dlPOP15, dlGHE, dlUrban, and dlFemalelfp. As a comparison, Tables 8 and 9 report the results under linear models, corresponding to linear model results in Tables 4  and 6 . The results show that none of these additional variables have been found to have an impact on health spending growth in those linear models, and for each of the remaining determinants, the significance of the results is similar to that in Tables 4 and 6 . The significant effects of dlPHE t − 1 , dlPGDP, and the Baumol variable on health spending growth are robust in linear models.
Tables 10 and 11 report the quantile regression results, as our earlier quantile regression model's results are presented in Tables 4 and 6 . For the sake of simplicity and clarity, we only present the quantile regression results after adding all five additional variables to the model, because the results are similar to those in other cases. Tables 12 and 13 contain the results of chi-square tests for the equality of the estimated coefficients across quantiles, corresponding to the estimated results shown in Tables 10 and 11, respectively.
With the comparison of the results in Tables 4 and 10 , and the other corresponding results in Tables 5 and 12 , some results show up. First, we find that, for all variables contained in Table 4 , the significance of the estimated results in Tables 4 and 10 is similar, and the chi-square tests indicate that the results corresponding to dlPHE t − 1 , dlPhy, dlPOP65, and dlLE65 presented in Table 12 are consistent with those in Table 5 , while no statistical difference in the effect of dlPGDP is found for any quantile pair after adding additional variables to the model. Second, for the additional variables, only the growth of percentage of urban population (dlUrban) and the growth of female labor participation (dlFemalelfp) are found to have a significant impact on the growth of health spending, and no significant result is found for the other three variables over the entire conditional distribution. Table 10 shows that, for a given percentage increase in variable dlUrban, health expenditure growth will slow in countries with lower levels of conditional growth of per capita health spending, while it can speed up health spending growth in countries with higher levels. Castro (2016) argued that the benefits of urbanization include the availability of health-care resources and lower travel costs and expected a negative effect on the health spending growth. He found an insignificantly negative effect of urbanization for the entire sample (156 countries) but a significantly positive effect of it for OECD countries. Our results show that the influence of dlUrban on the HCE growth relates to the conditional distribution of dlPHE. For the growth of female labor participation, a significantly negative effect is found in the lower tail of the distribution, and a significantly positive effect is found in the upper tail of the distribution. In other words, our results show that the impact of dlFemalelfp on the HCE growth also relates to the conditional distribution of dlPHE. Theoretically, a given percentage increase in female labor force participation rate is expected to grow HCE Castro, 2016) . Castro (2016) found a significantly negative effect of female labor force participation rate on the health-care spending growth for OECD countries and a significantly positive effect of it for non-OECD countries. In some ways, the findings of Castro (2016) support our results. As, like in the convergence models, countries with lower initial conditions have a tendency to grow faster, hence, the growth rate of health spending in those countries is more likely to be located at the right end of the conditional distribution. For this to be the case, our result indicates that an increase in dlFemalelfp speeds up the growth of health spending, which is consistent with the empirical findings for non-OECD countries found by Castro (2016) . Contrarily, countries with higher initial conditions tend to grow slower; the growth rate of health spending in those countries is likely to be located at the left end of the conditional distribution. If so, our result indicates that an increase in dlFemalelfp slows down the growth of health spending, which is also consistent with the empirical findings for OECD countries by Castro (2016) . With the comparison of the results in Tables 6 and 11 , and the corresponding results in Tables 7 and 13 , similar findings are obtained. For all variables contained in Table 6 , the significance of the estimated results in Tables 6 and 11 is similar, and the corresponding chi-square test results also indicate the same changing patterns for these variables. For the additional variables, the results presented in Table 11 are consistent with our earlier results shown in Table 10 , where, once again, only dlUrban and dlFemalelfp are found to have a significant impact on the growth of health spending.
In sum, these results further demonstrate that the impacts of the determinants on per capita HCE growth do vary with the conditional distribution, and the quantile regression results offer a much richer view than what could be achieved by looking at conditional mean models.
Prediction results for OECD countries
On the basis of the estimated results stated in the previous section, we can use it to make predictions. For the estimated results from Model (4), we can only use it to forecast the conditional mean of HCE growth for each OECD country. While using quantile regression dynamic panel data IVs model, we are able to examine how covariates influence the entire response distribution.
Using estimated results from Models 2 and 4, we construct densities for the one-step-ahead forecast. For Model (2), we estimate the conditional density functions using the simulation method proposed by Galvao (2011) . For Model (4), we make use of the normality assumption. As proposed by Galvao (2011) , letQ iT+1 ( | iT ,x iT+1 ) denote the conditional quantile function of y iT + 1 for a given country i. A draw from the one-step-ahead forecast distribution is given bŷi T+1 = Q iT+1 (U| iT ,x iT+1 ), where U is a uniformly distributed random variable on [0, 1]. We repeat 1,000 times to produce 1,000 predication samples of conditional quantile function of̂i T+1 , and then we apply kernel methods to predict the conditional densities.
For the estimates models presented in Table 4 , that is, where we set y it − 1 = dlPHE it − 1 ,x it = (dlPGDP it , dlPhy it , dlPOP65 it , dlLE65 it , Bau it ), the one-step-ahead forecast results are presented in Figure 5 . And for comparative purposes, letx iT+1 be the last observation in the sample. For the estimates models presented in Table 6 , that is, replacing the Baumol variable (Bau it ) with per capita wage growth (dlWage it ) and labor productivity growth (dlProd it ), the one-step-ahead forecast results are presented in Figure 6 .
Figures 5 and 6 show similarly prominent features. The results show evidence of similar estimates of the peak of the distributions for almost all countries, with the exception of Finland, Ireland, Japan, Korea, Luxembourg, the Netherlands, Norway, and Poland, although one important distinction is that the QRPIV model has a much higher peak in the center of the distribution than has the linear panel data model. And another important difference between the two methods is that QRPIV predicted values are much more concentrated, and also for almost all countries the QRPIV predicted densities are asymmetric. In addition, there are other patterns depicted in Figures 5 and 6 . First, the means are negative for Greece, Italy, Luxembourg, Portugal, and Spain, and almost all of the predictive values from QRPIV are negative for these countries. Thus, according to these estimates, these countries slowed down HCE growth in 2012, which is consistent with FIGURE 5 One-step-ahead predictive density functions for models presented in Table 4 . Note. The solid line is the one-step-ahead predictive conditional density based on quantile regression; the dashed line indicates the one-step-ahead predictive density based on the linear panel data model. In each panel, the predicted health-care expenditure growtĥi T+1 is measured along the horizontal axis, and the density is measured along the vertical axis [Colour figure can be viewed at wileyonlinelibrary.com] the realized growth rates in these countries. 4 It seems that the European sovereign debt crisis contributed to this result. And we find that all these countries experienced negative growth in per capita GDP during the crisis. Second, Figures 5  and 6 show that Estonia and Korea are likely to experience higher HCE growth rates than are other OECD countries in 2012, which is also consistent with the realized growth rates in these countries. Possible reasons for the rapid growth in Estonia are thought to be both the relatively low per capita health expenditure and positive per capita GDP growth. Following convergence theory, a country with a low initial level of HCE tends to grow faster. We find that, with the exception of Mexico, Estonia is the country with the lowest per capita HCE in our sample. For Korea, besides the determinants we consider in this study, some studies have concluded that the introduction of national health insurance is another factor that boosts the HCE growth (see, e.g., Tchoe & Nam, 2010) . In addition, Figures 5 and 6 depict slowly positive growth in Canada, Denmark, and Finland, and moderately positive growth in other 18 countries.
The results shown in Figures 5 and 6 illustrate that there is an important difference between the QRPIV model and the linear panel data model. Furthermore, benefiting from no explicit distribution assumptions on the densities of innovations in quantile regression models, it is reasonably believed that the quantile regression IV approach for dynamic panel data turns out to be advantageous to this study.
CONCLUSIONS
Most of the research into the determinants of health expenditure growth has been restricted to mean-type analyses. We have investigated the influence of determinants over the entire range of health expenditures growth by considering 28 OECD countries, and we used quantile regression techniques to examine changes in these influences on health spending growth at seven different quantiles: 0. 05, 0.10, 0.25, 0.50, 0.75, 0.90, and 0.95 . Specifically, we have considered the possibility of expenditure inertia by employing an IV quantile regression method for dynamic panel models with fixed effects. Additionally, given that few studies have examined the effect of the Baumol variable on the growth of health-care cost, we pay more attention on its effect. And also, one-step-ahead predictions are constructed for OECD countries.
FIGURE 6
One-step-ahead predictive density functions for models presented in Table 6 . Note. The solid line is the one-step-ahead predictive conditional density based on quantile regression; the dashed line indicates the one-step-ahead predictive density based on the linear panel data model. In each panel, the predicted health-care expenditure growtĥi T+1 is measured along the horizontal axis, and the density is measured along the vertical axis [Colour figure can be viewed at wileyonlinelibrary.com] With the use of a panel of 28 OECD countries over 23 years, a summary of our findings is as follows. (a) Overall, except for the Baumol variable and the growth of per capita GDP in some cases, the influence of the other significant determinants on the per capita health expenditure growth differs significantly at different quantiles, and the changing patterns of the determinants are also dissimilar. (b) The health expenditure inertia is significant and strong and increases with the increase in the conditional growth rate of per capita health spending. (c) Both the short-and long-run income elasticities of per capita health expenditure over the distribution are less than unity, indicating that health care is a necessity for the OECD countries. (d) The density of physicians has a significantly negative effect in the lower tail of the conditional distribution of health expenditures growth. (e) An increase in the percentage of the population that is aged 65 years and older has opposite effects on the lower and upper tails of the conditional distribution: An increase in the percentage will decrease the growth of health expenditure in countries with slower growth in health spending, while increasing the growth of health spending in countries with rapid growth in health spending. (f) The remaining life expectancy has a strong effect on health care, and the changing pattern of its influence is similar to that of the proportion of the population aged 65 years and older. (g) The Baumol variable has a significantly positive effect, and the effect of it is quite stable over the entire distribution. And more notably, one component of the Baumol variable, labor productivity growth, only exhibits significantly negative effect in the lower half of the conditional distribution, while the other component, wage growth, has a significantly positive effect on the whole distribution. (h) Both the growth of urbanization and growth of female labor force participation have an impact on health spending growth in the lower and upper tails of the conditional distribution, while no significant effect has been found for dlSugar, dlPOP15, and dlGHE. (i) The predictive density functions are quite different between the QRPIV model and linear panel data model for each OECD country, and we reasonably believe that the QRPIV model is advantageous to this study. Moreover, the forecasting results can be used to intervene in health expenditure growth.
Our findings have various implications for policy makers. Different policies are appropriate for controlling increases in health expenditure in different OECD countries, depending on the conditional growth rates of per capita HCE. Countries with low conditional levels do not need to worry too much, as increases in numbers of physicians and old people, and in life expectancies and labor productivity likely slow down the growth of health expenditure. For countries with high conditional levels, unfortunately, it seems that there is not much to do to restrain HCE from rising. Our results suggest that, perhaps, one unprepossessing way is to subdue the growth of wage.
